|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/30 | (1995.01) |
| C12N 5/12 | (1990.01) | ||
| A61P 35/00 | (2000.01) | ||
| A61K 39/395 | (1980.01) | ||
| A61P 43/00 | (2000.01) | ||
| A61P 35/04 | (2000.01) | ||
| A61P 37/04 | (2000.01) | ||
| C07K 16/28 | (1995.01) |
| (11) | Number of the document | 3401334 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18168460.6 |
| Date of filing the European patent application | 2008-05-27 | |
| (97) | Date of publication of the European application | 2018-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-02-15 |
| (46) | Date of publication of the claims translation | 2023-03-27 |
| (30) | Number | Date | Country code |
| 07010622 | 2007-05-29 | EP | |
| 932099 P | 2007-05-29 | US |
| (72) |
SAHIN, Ugur , DE
TÜRECI, Özlem , DE
BRANDENBURG, Gunda , DE
USENER, Dirk , DE
|
| (73) |
Astellas Pharma Inc. ,
5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku
Tokyo 103-8411,
JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui |
| MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 18 | 347.00 EUR |
| 2026-05-27 |